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Predictionide side chains to inﬂuenza virus hemagglutinin (HA) is believed to facilitate viral
escape from immune pressure in the human population. To determine the implicit potentials for acquisition
of N-linked glycosylation, we analyzed the genetic background of 16 subtypes of avian inﬂuenza virus, some
of which may be potential pandemic viruses in the future. We found a signiﬁcant difference among HA
subtypes in their genomic sequences to produce N-glycosylation sites. Notably, recently circulating avian
inﬂuenza viruses of the H5 and H9 subtypes may have rather greater capacities to undergo mutations
associated with glycosylation of HA than past pandemic viruses. We hypothesize that inﬂuenza viruses
maintained in natural reservoirs could have different potentials for sustained circulation, depending on their
HA subtypes, if introduced into the human population.
© 2008 Elsevier Inc. All rights reserved.Introduction
Inﬂuenza A viruses of all 16 hemagglutinin (H1–H16) and 9 neu-
raminidase (N1–N9) subtypes are maintained in aquatic birds
(Fouchier et al., 2005; Webster et al., 1992). Of these, only three
subtypes, H1N1, H2N2, and H3N2, caused pandemics in humans in the
last century (Horimoto and Kawaoka, 2005; Kilbourne, 1997).
Recently, direct avian-to-human transmission of H5N1, H7N3, H7N7,
and H9N2 avian inﬂuenza viruses has been reported (Fouchier et al.,
2004; Horimoto and Kawaoka, 2005; Peiris et al., 1999; Subbarao et al.,
1998). Although sustained human-to-human transmission has not yet
occurred, many researchers are concerned that a newglobal pandemic
could be caused by these viruses, which are antigenically different
from the H1, H2, and H3 subtypes.
HA is a surface glycoprotein composed of two structurally dis-
tinct regions: globular head and stem regions (Wilson et al., 1981).
It is the major target of antibodies that neutralize viral infectivity.
The accumulation of a series of amino acid substitutions under the
selection pressure of host immune responses results in antigenica).
l rights reserved.changes of inﬂuenza virus HAs. Amino acid substitutions asso-
ciated with the appearance of oligosaccharide side chains in the
globular head region are believed to efﬁciently generate antigenic
variants.
The number of N-glycosylation sequons (Asn-Xaa-Ser/Thr, where
Xaa is any amino acid except Pro) in the globular head region of
H3 HA has been increasing during circulation in the human pop-
ulation for 39 years (Abe et al., 2004; Seidel et al., 1991; Zhang et al.,
2004). Most of the currently circulating H3N2 viruses have six or
seven N-glycosylation sequons in the HA globular head region,
whereas HA of the prototype H3N2 strain isolated in 1968, A/Hong
Kong/1/68 (H3N2), had only two sites (Fig. 1A). The H1N1 virus has
also been circulating in humans for 30 years since its reemergence in
1977. Recent H1N1 viruses possess more N-glycosylation sequons in
their HA sequences (Zhang et al., 2004) than the pandemic H1N1
strain, A/South Carolina/1/18 (H1N1), which was detected from a few
victims of the 1918 inﬂuenza (Reid et al., 1999) (Fig. 1B). By contrast,
HAs of H2N2 viruses did not acquire a new N-glycosylation sequon in
the globular head region during the period of H2N2 epidemics (1957–
1968) (Fig. 1C). These epidemiological observations have led to the
hypothesis that the addition of new carbohydrate side chains to HA is
an important factor for sustained circulation of inﬂuenza viruses in
the human population (Abe et al., 2004; Schulze, 1997; Seidel et al.,
Fig. 1. Sequence data analyses of human and avian inﬂuenza virus HAs. The number of
N-glycosylation sequons was examined for human H3N2 (A), H1N1 (B), and H2N2 (C)
viruses. In each box plot, the median value is indicated by a solid horizontal bar. The
top and bottom edges of the box mark the ﬁrst and third quartile, respectively.
Outliers, which are shown as open circles, are cases with values more than 1.5 times
the interquartile range away from the upper or lower quartile. The whiskers
extending from the box indicate the highest and lowest values, excluding the
outliers. The virus names and accession numbers used in this study are listed in
Supplemental Table 1.
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HAs of different subtypes and compared their genetic background for
antigenic changes associated with N-glycosylation.
Results and discussion
To trace the history of the codon changes that resulted in the
acquisition of sequons in the globular head region of HA of the human
H3N2 virus, we investigated potential candidate codons that were
not sequons and became sequons with 1–3 nucleotide mutations
during its epidemics over the last 39 years. Sets of three codons thatrequire single, double, or triple nucleotide substitutions to produce
sequons are denoted as Cand1, Cand2, and Cand3 sites, respectively
(Fig. 2). We found that all these additional sequons in H3 HAs were
derived from Cand1, Cand2, or Cand3 sites (Fig. 3). The N-glycosyla-
tion sequons acquired in the ﬁrst 20 years (Asn residues 63, 126, and
246) were Cand1 sites in HA of the prototype virus strain isolated in
1968. Two N-glycosylation sequons at Asn 122 and Asn 133 acquired
in 1997 and an N-glycosylation sequon at Asn 144 acquired in 2003
were Cand2 and Cand3 sites, respectively, in HA of the prototype
strain. These results suggest that Cand1 sites in the H3 prototype
strain were important motifs to rapidly acquire N-glycosylation
sequons and that Cand2 and Cand3 sites also contributed to the
addition of oligosaccharide chains during the evolution of the H3N2
virus in humans. Because N-glycosylation in the globular head region
is believed to facilitate viral escape from neutralization by antibodies,
the number of Cand1, Cand2, and Cand3 sites in the H3N2 pandemic
strain could be one of the key factors prerequisite for continuous
circulation of this virus in the human population.
We could not trace the history of the codon changes of the human
H1N1 virus, because there is little information on the HA sequences of
the human H1N1 virus isolated before its reemergence in 1977.
However, we found that the prototype strain, A/South Carolina/1/18,
had the only N-glycosylation sequon at Asn residues 94A (H3
numbering) in the globular head region of HA, and H1N1 virus that
reemerged in 1977 possessed ﬁve N-glycosylation sequons at Asn
residues 94A, 131, 158, 163, and 271. In addition, most of recent H1N1
viruses have four N-glycosylation sequons at Asn residues 63, 94A,
129, and 163. It is noted that newly added N-glycosylation sequons
were derived from the Cand1, Cand2, or Cand3 sites in HA of the
prototype virus strain (data not shown), suggesting the importance of
these sites for the evolution of the H1N1 inﬂuenza virus in the human
population.
As noted above, our retrospective analysis of human inﬂuenza
viruses suggested that the presence of Cand1 and Cand2 sites in
HA genes is one of the key factors for the viruses to rapidly acquire
N-glycosylation sequons during their evolutionary process. This
prompted us to investigate the number of Cand1 and Cand2 sites in
avian inﬂuenza viruses of all 16 subtypes, some of which may be
potential human pandemic viruses in the future. All 16 HA subtypes
were compared to each other to assess their potentials to acquire
N-glycosylation sequons. We found that the distribution of the
number of Cand1 and Cand2 sites varied widely among the HA
subtypes (Figs. 4B and C), with signiﬁcant differences (Tables 1
and 2), while 1–2 actual N-glycosylation sequons were similarly
present in most of the HA subtypes (Fig. 4A). Therefore, we hypo-
thesized that the ability of these avian viruses to rapidly acquire
the N-glycosylation sequons associated with the antigenic change
to evade antibody-mediated immune pressure in the human pop-
ulation may be different among the HA subtypes. From this point of
view, avian H1 and H3 viruses had more Cand1 sites in the globular
head regions of HAs than avian H2 viruses. The same was equally
true of the prototype strains of human inﬂuenza viruses in previous
pandemics, A/South Carolina/1/18 (H1N1), A/Japan/305/57 (H2N2),
and A/Hong Kong/1/68 (H3N2). We also compared the total number
of Cand1 plus Cand2 (Cand1+2) sites among HA subtypes, and
found that avian H1 and H3 viruses had signiﬁcantly larger num-
bers of Cand1+2 sites than avian H2 viruses (data not shown).
Although the H2N2 virus did not acquire a new N-glycosyla-
tion sequon during the period of its epidemics, escape mutants of
the virus selected by using monoclonal antibodies acquired new
N-glycosylation sites at three positions (160, 187 or 131), suggesting
that this virus also had the potential to acquire new N-glycosylation
sequons (Tsuchiya et al., 2001, 2002a,b). However, due to the
additional glycosylation, these escape mutants of the H2N2 virus
signiﬁcantly decreased the biological activities of their HAs, whereas
H3N2 viruses could acquire a new oligosaccharide in the globular
Fig. 2. Examples of potential candidate codons for N-glycosylation sequons. Nucleotide sequences shown in (A) are representative codons of the Cand1 sites (i.e., Cand1 sites become
sequons with single nucleotide substitution). (B) and (C) show examples of the Cand2 and Cand3 sites, respectively. The Cand2 and Cand3 sites become sequons with double and
triple nucleotide mutations, respectively.
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These results may suggest a conformational constraint of the H2 HA
molecule. Moreover, our analysis indicated that the number of Cand1
sites in the prototype strain of the human H2N2 virus A/Japan/305/
57 was smaller than those of the human H1N1 (A/South Carolina/1/
18) and H3N2 (A/Hong Kong/1/68) viruses (Supplemental Table 1).
Thus, it is conceivable that the H2N2 virus already had a disad-
vantage at the time of its appearance in the human population.
Another possibility is that the H2N2 viruses that had acquired a
new glycosylation site during the period of their epidemics lost the
glycosylation site due to the egg adaptation (Gambaryan et al.,
1999), since these viruses might have undergone multiple egg
passages in the 50s and 60s before virus sequencing was
performed. Overall, several factors seem to inﬂuence the observa-
tion that the number of N-glycosylation sequons in the globular
head region of human H2 HA stayed constant (Fig. 1C).
For long-term circulation of inﬂuenza A viruses in the human
population, it seems important for the viruses to acquireN-glycosylation
sites in the early period of the epidemic inhumans. Our analyses showed
that Cand1 sites were important motifs to contribute to this ability. As
shown in Fig. 4B, H1 virus has the number of Cand1 sites comparable to
that of H3 virus. Accordingly, both human H1N1 and H3N2 viruses
rapidly acquired N-glycosylation sequons after their emergence. On the
other hand, Cand2 sites also contributed to the accumulation of
glycosylation sites during the circulation of human H3N2 virus. As
shown in Fig. 4C, H1 virus had a signiﬁcantly smaller number of Cand2
sites thanH3virus. Thismay suggest that humanH1N1virus has limited
ability to acquireN-linked glycosylation sites in the future, as compared
with human H3N2 virus. However, since N-glycosylation is not the only
mechanism underlying the antigenic change (Wiley et al., 1981) and
there will be a limit of the number of actual N-glycosylation sites, it is
interesting to investigate future evolution that will be found in these
human viruses.
Avian inﬂuenza viruses of the H5, H6, H7, and H9 subtypes have
been circulating in domestic poultry over the past 10 years. Since the
ﬁrst human case of H5N1virus was identiﬁed in Hong Kong in 1997,
direct avian-to-human transmission of several avian viruses, including
H5N1, H7N7, H7N3, and H9N2, has been reported (Fouchier et al.,
2004; Horimoto and Kawaoka, 2005; Peiris et al., 1999; Subbarao et al.,
1998). These avian viruses pose a potential pandemic threat to
humans. Our analyses demonstrate that avian H5 and H9 viruses have
a signiﬁcantly larger number of Cand1 sites in the HA globular head
regions than H2 virus (Fig. 4B), and they are comparable to or have
rather more such sites than avian H1 and H3 viruses (Table 1). In
addition, the number of Cand2 sites in HAs of avian H5 viruses is
larger than that found in avian H1 HAs and comparable with that in
avian H3 HAs (Table 2). Avian H9 virus also has a number of Cand2
sites comparable to that of the H1 virus. Accordingly, the recentlycirculating avian H5N1 virus (genotype Z) has already acquired a
carbohydrate chain at position 158 (H3 numbering) (Li et al., 2004).
Thus, we suggest that avian H5 and H9 viruses may have greater
abilities to rapidly acquire N-glycosylation sequons than past
pandemic viruses if introduced as new pandemic viruses in the
human population. On the other hand, avian H7 virus has a
signiﬁcantly smaller number of both Cand1 and Cand2 sites than
avian H2 virus (Figs. 4B and C), suggesting that avian H7 virus may
have less ability to acquire N-glycosylation sites on the surface of the
HA molecules.
Avian H4 and H6 viruses have a higher number of Cand1 sites,
and avian H8, H13, and H14 viruses have a higher number of Cand2
sites than avian H3 virus (Figs. 4B and C). Although these avian
viruses have not been associated with human infections, our hy-
pothesis may suggest that these viruses have greater abilities to
rapidly acquire N-glycosylation sequons under antibody-mediated
immune pressure in the human population. However, it is generally
accepted that avian inﬂuenza viruses require multiple mutations
to be adapted to mammalian hosts, including humans (Horimoto
and Kawaoka, 2001; Kuiken et al., 2006). Thus, acquisition of these
mutations should be a prerequisite to exert the hypothetical ability of
antigenic change associated with N-glycosylation.
We further investigated the potential of mutations to acquire
carbohydrate side chains on a three-dimensional model of HA
molecules of H3, H2, and H5 subtypes (Fig. 5). Consistent with the
difference among these HA subtypes of avian inﬂuenza viruses in the
number of Cand1 sites found in their original amino acid sequences
(Figs. 4B and C), HA of the prototype strain of human H2N2 pandemic
inﬂuenza virus expressed a smaller number of amino acids involved in
N-glycosylation sequons and Cand1 sites on the solvent-accessible
surface area of the HA molecule than H3 and H5 HAs. More
importantly, recently circulating avian H5N1 viruses have a larger
number of Cand1 sites on the surface of the HA molecule than
prototype strains of human H3N2 and H2N2 pandemic viruses. It
should be noted that some of these Cand1 sites on H5 HA are located
at positions nearly identical to those actually glycosylated on HA of
recent human H3N2 viruses (i.e., positions 63, 123, 144, and 165 in H5
HA).
In the present study, we analyzed a large number of nucleotide
sequences of inﬂuenza virus HAs of different subtypes and
compared their implicit potentials to acquire oligosaccharide
chains. Importantly, there is a signiﬁcant difference among avian
HA subtypes in the genomic sequences needed to produce new N-
glycosylation sequons, leading to the hypothesis that avian
inﬂuenza viruses maintained in natural reservoirs have different
abilities to rapidly evolve with N-glycosylation of HA if introduced
into new host animals and exposed to immune pressure, and this
depends on the HA subtype. Although this hypothesis still needs to
Fig. 3. Summary of the history of N-glycosylation sequons in HA of human H3N2 viruses isolated between 1968 and 2007. Data represent themajority sequence obtained at each time
point. The sequon at Asn residue 165 has been present for 39 years, and the sequon at Asn residue 81 has been lost since 1974.
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oligosaccharide attachment (Petrescu et al., 2004), our approach
may provide a possible way to predict the potentials for sustainedFig. 4. Comparison of the N-linked glycosylation capacities among 16 HA subtypes of
avian inﬂuenza viruses. The number of N-glycosylation sequons (A), Cand1 (B), and
Cand2 (C) sites of 16 HA subtypes of avian inﬂuenza viruses was compared by a two-
sided nonparametric test. Box plots are drawn as described in the legend of Fig. 1.circulation of a hypothetical new pandemic inﬂuenza virus in the
human population.
Materials and methods
Sequence data of HA genes
Nucleotide sequences for HA genes of inﬂuenza A viruses were
downloaded from the Inﬂuenza Virus Resource at the National Center
for Biotechnology Information (NCBI) (http://www.ncbi.nlm.nih.gov/
genomes/FLU/FLU.html) (Chang et al., 2007) as of July 10, 2007.
Sequence data containing ambiguous nucleotides were excluded. We
used 950, 88, and 3415 sequences of H1N1, H2N2, and H3N2 human
inﬂuenza viruses, respectively, for the retrospective analyses, and 47
(H1), 70 (H2), 104 (H3), 113 (H4), 747 (H5), 177 (H6), 66 (H7), 10 (H8),
89 (H9), 25 (H10), 52 (H11), 21 (H12), 15 (H13), 2 (H14), 5 (H15), and 6
(H16) sequences for comparison among avian viruses. We focused on
virus strains isolated from the Anseriformes and Charadriiformes that
are known as natural reservoirs of all inﬂuenza A viruses. Human
isolates that might have avian or swine origins were excluded in the
retrospective analyses. For each subtype of HA, multiple-alignment of
the nucleotide sequences was performed using the computer program
MUSCLE (version 3.6) (Edgar, 2004a,b). Then we extracted the partial
sequences coding the globular head region. We deﬁned the globular
head region as amino acid positions 52 to 277 (H3 numbering) for all
HA subtypes. The virus names and accession numbers used in this
study are listed in Supplemental Table 1.
Sequence data analyses
Custom-made programs were developed with the Ruby language
and used for counting the number of N-glycosylation sequons, and
potential candidate codons (Cand1, Cand2, and Cand3) in amino acid
sequences corresponding to the globular head region of HA (Fig. 2).
The programs are available upon request.
Statistical analysis
The data of all 16 HA subtypes were analyzed using Kruskal–Wallis
ANOVA on ranks. The differences between subtypes were compared
using theMann–Whitney U-test with the Bonferroni–Holm correction
for multiple comparisons (Holm, 1979). All reported P values were
two-sided. P values of less than 0.05 were considered signiﬁcant. All
statistical analyses were performed with the computer program R
(version 2.2.1).
Homology modeling
Ahomologymodel of the humanH2N2 virus (A/Japan/305/1957) HA
was constructed based on the crystal structure of H5N1 virus HA (PDB
Table 1
Comparison of the number of Cand1 sites between HA subtypes of avian inﬂuenza viruses
H1 H2 H3 H4 H5 H6 H7 H8 H9 H10 H11 H12 H13 H14 H15 H16
H1 H1NH2a n.s.b H1bH4 n.s. H1bH6 H1NH7 H1NH8 H1bH9 H1bH10 n.s. H1NH12 H1NH13 n.s. H1NH15 H1NH16
H2 b0.0001a H2bH3 H2bH4 H2bH5 H2bH6 H2NH7 n.s. H2bH9 H2bH10 H2bH11 H2NH12 H2NH13 n.s. H2NH15 H2NH16
H3 1.0000 b0.0001 H3bH4 n.s. H3bH6 H3NH7 H3NH8 H3bH9 n.s. n.s. H3NH12 H3NH13 n.s. H3NH15 H3NH16
H4 b0.0001 b0.0001 b0.0001 H4NH5 H4NH6 H4NH7 H4NH8 H4NH9 H4NH10 H4NH11 H4NH12 H4NH13 n.s. H4NH15 H4NH16
H5 0.2314 b0.0001 1.0000 b0.0001 H5bH6 H5NH7 H5NH8 H5bH9 n.s. n.s. H5NH12 H5NH13 n.s. H5NH15 H5NH16
H6 b0.0001 b0.0001 b0.0001 b0.0001 b0.0001 H6NH7 H6NH8 H6NH9 H6NH10 H6NH11 H6NH12 H6NH13 n.s. H6NH15 H6NH16
H7 b0.0001 b0.0001 b0.0001 b0.0001 b0.0001 b0.0001 H7bH8 H7bH9 H7bH10 H7bH11 n.s. n.s. n.s. H7NH15 n.s.
H8 b0.0001 1.0000 b0.0001 b0.0001 b0.0001 b0.0001 0.0001 H8bH9 H8bH10 H8bH11 H8NH12 n.s. n.s. H8NH15 n.s.
H9 b0.0001 b0.0001 0.0003 b0.0001 b0.0001 b0.0001 b0.0001 b0.0001 n.s. H9NH11 H9NH12 H9NH13 n.s. H9NH15 H9NH16
H10 0.0181 b0.0001 0.7067 b0.0001 0.1641 b0.0001 b0.0001 0.0003 1.0000 n.s. H10NH12 H10NH13 n.s. H10NH15 H10NH16
H11 0.4779 b0.0001 1.0000 b0.0001 1.0000 b0.0001 b0.0001 b0.0001 0.0373 1.0000 H11NH12 H11NH13 n.s. H11NH15 H11NH16
H12 b0.0001 0.0012 b0.0001 b0.0001 b0.0001 b0.0001 1.0000 0.0233 b0.0001 b0.0001 b0.0001 n.s. n.s. n.s. n.s.
H13 b0.0001 0.0011 b0.0001 b0.0001 b0.0001 b0.0001 1.0000 0.0852 b0.0001 b0.0001 b0.0001 1.0000 n.s. n.s. n.s.
H14 1.0000 0.4779 1.0000 0.4174 1.0000 0.7233 0.4264 0.6234 1.0000 1.0000 1.0000 0.4779 0.7233 n.s. n.s.
H15 0.0058 0.0082 0.0061 0.0056 0.0027 0.0056 0.0312 0.0481 0.0073 0.0181 0.0065 0.0815 1.0000 0.7146 n.s.
H16 0.0216 1.0000 0.0223 0.0013 0.0050 0.0016 1.0000 1.0000 0.0062 0.0176 0.0113 1.0000 1.0000 1.0000 0.1762
a Differences between HA subtypes (above the diagonal) were evaluated by P values (below the diagonal) and Fig. 4B. P values of less than 0.05 were considered statistically
signiﬁcant.
b n.s.; not signiﬁcant.
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modeller.html) (Eswar et al., 2003). The sequence of A/Japan/305/1957
was obtained from NCBI Inﬂuenza Virus Resource (accession number
J02127). After one hundredmodels of the HA trimerwere generated,we
selected themodel with the best probability distribution function (PDF)
score and assessed its structure also by using the discrete optimized
protein energy (DOPE) scoring function (Shen andSali, 2006). Themodel
was reﬁned by energy minimization (EM) with the minimization
protocols in the Discovery Studio 1.7 (Accelrys, Inc., http://www.
accelrys.com/dstudio/) software package using a CHARMm force ﬁeld.
After addition of hydrogen atoms, all side chain atoms were minimized
by ﬁxing the backbone atoms. Steepest descent followed by conjugate
gradientminimizationswas carried out until the rootmeansquare (rms)
gradient was less than 0.1 kcal/mol/Å. Then the adopted basis Newton
Raphson algorithmwas employed until the rms gradient was less than
0.01 kcal/mol/Å. Finally, the same procedures were performed without
ﬁxing any atomic coordinates. The generalized Born implicit solvent
model (Still et al., 1990; Tsui and Case, 2000) was used to model the
effects of solvation. The HA model was ﬁnally evaluated by using
PROCHECK (Laskowski et al.,1993),WHATCHECK (Hooft et al.,1996), and
VERIFY-3D (Eisenberg et al., 1997).Table 2
Comparison of the number of Cand2 sites between HA subtypes of avian inﬂuenza viruses
H1 H2 H3 H4 H5 H6 H7 H8 H
H1 n.s.b H1bH3a n.s. H1bH5 n.s. H1NH7 H1bH8 H
H2 1.0000a H2bH3 n.s. H2bH5 n.s. H2NH7 H2bH8 H
H3 b0.0001 b0.0001 H3NH4 n.s. H3NH6 H3NH7 H3bH8 H
H4 1.0000 1.0000 b0.0001 H4bH5 n.s. H4NH7 H4bH8 H
H5 b0.0001 b0.0001 1.0000 b0.0001 H5NH6 H5NH7 H5bH8 H
H6 1.0000 0.4662 b0.0001 1.0000 b0.0001 H6NH7 H6bH8 H
H7 b0.0001 b0.0001 b0.0001 b0.0001 b0.0001 b0.0001 H7bH8 H
H8 b0.0001 b0.0001 0.0004 b0.0001 b0.0001 b0.0001 b0.0001 H
H9 0.0002 b0.0001 b0.0001 b0.0001 b0.0001 0.0367 b0.0001 b0.0001
H10 0.0724 0.0149 b0.0001 0.0881 b0.0001 1.0000 b0.0001 0.0003 1
H11 b0.0001 b0.0001 b0.0001 b0.0001 b0.0001 b0.0001 0.0017 b0.0001 b
H12 0.0311 0.0105 b0.0001 0.0645 b0.0001 1.0000 b0.0001 0.0006 1
H13 b0.0001 b0.0001 0. 1130 b0.0001 0.0129 b0.0001 b0.0001 0.3655 b
H14 0.6148 0.6148 1.0000 0.5843 1.0000 0.5843 0.6148 1.0000 0
H15 1.0000 1.0000 0.0130 1.0000 0.0060 1.0000 0.0311 0.1089 0
H16 1.0000 1.0000 0.0042 1.0000 0.0013 1.0000 0.0446 0.0585 0
a Differences between HA subtypes (above the diagonal) were evaluated by P values (be
signiﬁcant.
b n.s.; not signiﬁcant.Acknowledgments
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5NH9 H5NH10 H5NH11 H5NH12 H5bH13 n.s. H5NH15 H5NH16
6bH9 n.s. H6NH11 n.s. H6bH13 n.s. n.s. n.s.
7bH9 H7bH10 H7NH11 H7bH12 H7bH13 n.s. H7bH15 H7bH16
8NH9 H8NH10 H8NH11 H8NH12 n.s. n.s. n.s. n.s.
n.s. H9NH11 n.s. H9bH13 n.s. n.s. n.s.
.0000 H10NH11 n.s. H10bH13 n.s. n.s. n.s.
0.0001 b0.0001 H11bH12 H11bH13 n.s. H11bH15 H11bH16
.0000 1.0000 b0.0001 H12bH13 n.s. n.s. n.s.
0.0001 b0.0001 b0.0001 b0.0001 n.s. n.s. H13NH16
.5972 0.7529 0.6148 0.7831 1.0000 n.s. n.s.
.8166 1.0000 0.0129 1.0000 0.0576 1.0000 n.s.
.8866 1.0000 0.0042 1.0000 0.0266 1.0000 1.0000
low the diagonal) and Fig. 4C. P values of less than 0.05 were considered statistically
Fig. 5. The N-glycosylation sequons and Cand1 sites in solvent-accessible surface area representations of HA trimer structures. Three-dimensional models of H3 (STRAIN X-31) (A)
and H5 (A/Vietnam/1194/04) (C) HAs were constructed from the coordinates obtained from the Protein Data Bank (PDB code: 1HGF and 2IBX, respectively). The structure of H2 (A/
Japan/305/1957) HA (B) was constructed by homology modeling. Residues shown in blue and red represent Asn at ﬁrst positions in the present N-glycosylation sequons and amino
acids that require nucleotide substitutions to produce sequons in Cand1 sites, respectively. Images were prepared by using MolFeat software (version 3.0, FiatLux Co.). Residue
numbering is thoroughly on the basis of the H3 HA sequence. The numbers in parentheses show the positions of Asn residues that may be linked to carbohydrate chains, if respective
Cand1 sites are mutated to N-glycosylation sequons.
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